Prevalence of Extended-spectrum Beta-lactamase (ESBL), Metallo Beta-lactamase (MBL) and Carbapenemase Producing Acinetobacter Species Isolated from Various Clinical Samples in Tertiary Care Hospital

被引:1
|
作者
Yadav, Manasi Vikas [1 ,2 ]
Karande, Geeta S. [1 ,2 ]
Karande, S. N. [2 ,3 ]
Patil, S. R. [1 ,2 ]
Sharma, Shanu [1 ,2 ]
机构
[1] Krishna Inst Med Sci, Dept Microbiol, Karad, India
[2] Deemed Univ Karad, Krishna Vishwa Vidyapeeth, Malkapur, Maharashtra, India
[3] Krishna Inst Med Sci, Dept ENT, Karad, India
关键词
ANTIMICROBIAL RESISTANCE; BAUMANNII; SPP;
D O I
10.22207/JPAM.18.1.36
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Acinetobacter is an important nosocomial pathogen causing health care associated infections. It is highly antibiotic resistant gram-negative bacilli. The study was done to determine the prevalence of Acinetobacter species isolated from various clinical samples with their antibiotic susceptibility pattern. To determine the antimicrobial susceptibility pattern of the isolated Acinetobacter species and also the multidrug resistant mechanisms by phenotypic characterization. The retrospective study was carried out in patients diagnosed with Acinetobacter infection in the Microbiology Department, Krishna Institute of Medical Sciences, Krishna Vishwa Vidyapeeth, Deemed To Be University, Karad, a tertiary care hospital, including the clinical departments, during the period of two years from November 2020 till November 2022. Organism identification, biochemical test, antibiotic resistance pattern and phenotypic tests such as ESBL, MBL and Carbapenemase production were performed as per the Clinical and Laboratory Standards Institute (CLSI). The Modified Hodge test (MHT) was performed for Carbapenemase production detection in Acinetobacter species. A total of 150 Acinetobacter species were isolated from clinical samples. Acinetobacter baumannii was the most prevalent species 138 (92%), followed by Acinetobacter lwoffii 10 (7%) and Acinetobacter hemolyticus 2 (1%). The isolates showed highest resistance to Ampicillin 130 (87%) and sensitive to Colistin 113 (75.3%). Most of the isolates of of Acinetobacter baumannii showed maximum ESBL 21(14%) and MBL 75 (93%) production. Modified Hodge test showed positive results in Acinetobacter baumannii, only 11 (7%). The study showed that Acinetobacter baumannii was the most prevalent species showing drug resistance by phenotypic detection methods. At present Acinetobacter is a frequent pathogen in hospital acquired infections in critically ill patients admitted to ICU. The isolates of Acinetobacter species in our study showed resistant to most commonly used antibiotics. The study showed that ESBL production in Acinetobacter was 22 (15%) and MBL 80 (53%). Most Acinetobacter isolates were Multi Drug Resistant (MDR). MDR Acinetobacter is widely increasing due to inappropriate use of antibiotics in healthcare hospital. In our study, detection of carbapenemase by Modified Hodge test was positive in 11 (7%) isolates.
引用
收藏
页码:528 / 541
页数:14
相关论文
共 50 条
  • [21] Identification, Speciation and Antibiogram along with Detection of Metallo Beta-lactamase Production in Acinetobacter Isolated from Clinical Samples in a Tertiary Care Hospital
    Chitrabanu, N. Ashwin
    Mallya, Shrikara
    JOURNAL OF PURE AND APPLIED MICROBIOLOGY, 2021, 15 (02): : 839 - 844
  • [22] Prevalence of multidrug resistant and extended spectrum beta-lactamase producing Pseudomonas aeruginosa in a tertiary care hospital
    Shaikh, Sibhghatulla
    Fatima, Jamale
    Shakil, Shazi
    Rizvi, Syed Mohd. Danish
    Kamal, Mohammad Amjad
    SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2015, 22 (01) : 62 - 64
  • [23] Antibiotic resistance profile & extended spectrum beta-lactamase (ESBL) production in Acinetobacter species
    Sinha, Mahua
    Srinivasa, H.
    Macaden, R.
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2007, 126 (01) : 63 - 67
  • [24] Treatment options for extended-spectrum beta-lactamase (ESBL) and AmpC-producing bacteria
    D'Angelo, Ryan G.
    Johnson, Jennifer K.
    Bork, Jacqueline T.
    Heil, Emily L.
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (07) : 953 - 967
  • [25] Detection of extended-spectrum beta-lactamase (ESBL) production by disc diffusion method among Pseudomonas species from various clinical samples
    Kothari, Ashish
    Kumar, Shailesh
    Omar, Balram Ji
    Kiran, Kamini
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2020, 9 (02) : 683 - 693
  • [26] Prevalence of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli in healthy individuals in Bavaria, Germany
    Valenza, G.
    Nickel, S.
    Pfeifer, Y.
    Krupa, E.
    Lehner-Reindl, V.
    Hoeller, C.
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2013, 303 : 93 - 93
  • [27] Prevalence of multidrug-resistant and extended-spectrum beta-lactamase producing Gram-negative isolates from clinical samples in a tertiary care hospital of Nepal
    Shilpakar, Aryatara
    Ansari, Mehraj
    Rai, Kul Raj
    Rai, Ganesh
    Rai, Shiba Kumar
    TROPICAL MEDICINE AND HEALTH, 2021, 49 (01)
  • [28] Prevalence of multidrug-resistant and extended-spectrum beta-lactamase producing Gram-negative isolates from clinical samples in a tertiary care hospital of Nepal
    Aryatara Shilpakar
    Mehraj Ansari
    Kul Raj Rai
    Ganesh Rai
    Shiba Kumar Rai
    Tropical Medicine and Health, 49
  • [29] Perceptions of Carriership of Extended-Spectrum Beta-Lactamase (ESBL)-Producing Bacteria: A Qualitative Study
    Uggla, Karin
    Razmi, Robin
    Jaerhult, Josef D.
    Lindberg, Maria
    NURSING REPORTS, 2024, 14 (03) : 1819 - 1827
  • [30] Extended-spectrum beta-lactamase producing Enterobacteriaceae (ESBL-E) isolated from bean sprouts in the Netherlands
    Huizinga, Pepijn
    Schrauwen, Eefje
    Garcia-Cobos, Silvia
    Willemsen, Ina
    Verhulst, Carlo
    Friedrich, Alexander W.
    Savelkoul, Paul H. M.
    Rossen, John W.
    Kluytmans, Jan
    PLOS ONE, 2018, 13 (08):